Selective serotonin-reuptake inhibitors and chemoprevention of colorectal cancer

被引：2
|
作者：
Sorensen, HT [1 ]
机构：
[1] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus C, Denmark
来源：
LANCET ONCOLOGY | 2006年 / 7卷 / 04期
关键词：
D O I：
10.1016/S1470-2045(06)70627-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：277 / 279
页数：3
相关论文
共 50 条
  • [31] Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects
    Alwan, Sura
    Reefhuis, Jennita
    Rasmussen, Sonja A.
    Olney, Richard S.
    Friedman, Jan M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (26): : 2684 - 2692
  • [32] Effects of selective serotonin-reuptake inhibitors (SSRIs) on human villous trophoblasts syncytialization
    Clabault, Helene
    Flipo, Denis
    Guibourdenche, Jean
    Fournier, Thierry
    Sanderson, J. Thomas
    Vaillancourt, Cathy
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2018, 349 : 8 - 20
  • [33] Are the antiplatelet and profibrinolytic properties of selective serotonin-reuptake inhibitors relevant to their brain effects?
    Hoirisch-Clapauch, Silvia
    Nardi, Antonio E.
    Gris, Jean-Christophe
    Brenner, Benjamin
    THROMBOSIS RESEARCH, 2014, 134 (01) : 11 - 16
  • [34] Antenatal use of selective serotonin-reuptake inhibitors and QT interval prolongation in newborns
    Dubnov-Raz, Gal
    Juurlink, David N.
    Fogelman, Rami
    Merlob, Paul
    Ito, Shinya
    Koren, Gideon
    Finkelstein, Yaron
    PEDIATRICS, 2008, 122 (03) : E710 - E715
  • [35] Selective Serotonin-reuptake inhibitors (SSRI) in treatment of child and adolescent psychiatry disorders
    Stilke, D
    ZEITSCHRIFT FUR KINDER-UND JUGENDPSYCHIATRIE UND PSYCHOTHERAPIE, 1997, 25 (02): : 106 - 116
  • [36] Lack of clinical evidence for potential interaction between isoniazid and selective serotonin-reuptake inhibitors
    Stockley, IH
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (18) : 2217 - 2217
  • [37] Chlorpheniramine, selective serotonin-reuptake inhibitors (SSRIs) and over-the-counter (OTC) treatment
    Hellbom, E
    MEDICAL HYPOTHESES, 2006, 66 (04) : 689 - 690
  • [38] Selective Serotonin-Reuptake Inhibitors and Risks of Persistent Fetal Circulation and Pulmonary Hypertension in the Newborn
    Kieler, Helle
    Furu, Kari
    Gissler, Mika
    Noergaard, Mette
    Valdimarsdottir, Unnur
    Haglund, Bengt
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S10 - S10
  • [39] Maternal Use of Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn
    Alwan, S.
    Bandoli, G.
    Chambers, C. D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 100 (01) : 34 - 41
  • [40] First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects
    Louik, Carol
    Lin, Angela E.
    Werler, Martha M.
    Hernandez-Diaz, Sonia
    Mitchell, Allen A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (26): : 2675 - 2683
12345